Published in J Pediatr on January 01, 1994
Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice. Hepatology (2015) 1.65
Progressive familial intrahepatic cholestasis. Orphanet J Rare Dis (2009) 1.38
Gastrointestinal and hepatic manifestations of primary immune deficiency diseases. Saudi J Gastroenterol (2010) 0.88
Imaging of biliary disorders in children. Pediatr Radiol (2010) 0.81
Primary sclerosing cholangitis preceding Crohn's disease in a child with Down's syndrome. Dig Dis Sci (1998) 0.80
Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experience. Dig Dis Sci (2009) 0.77
Pediatric liver transplantation for primary sclerosing cholangitis. Liver Transpl (2011) 0.77
Pathogenesis and clinical spectrum of primary sclerosing cholangitis. World J Gastroenterol (2017) 0.75
Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature (1998) 7.76
Sequences of mouse immunoglobulin light chain genes before and after somatic changes. Cell (1978) 7.53
Sequence of a mouse germ-line gene for a variable region of an immunoglobulin light chain. Proc Natl Acad Sci U S A (1978) 6.80
Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours. EMBO J (1983) 5.93
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. Leukemia (2009) 4.53
Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell (1996) 4.05
Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases. J Pediatr (1987) 3.50
Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release. Neuron (2001) 3.47
Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: comparison with results for other viral markers. Hepatology (1983) 3.11
Detection of hepatitis B virus DNA in liver and serum: a direct appraisal of the chronic carrier state. Lancet (1981) 2.80
Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature (1991) 2.67
Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology (1999) 2.61
Sequences of the joining region genes for immunoglobulin heavy chains and their role in generation of antibody diversity. Proc Natl Acad Sci U S A (1981) 2.38
State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases. Proc Natl Acad Sci U S A (1981) 2.37
Two forms of the basic fibroblast growth factor receptor-like mRNA are expressed in the developing mouse brain. Proc Natl Acad Sci U S A (1990) 2.17
Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci U S A (1998) 2.17
Transcriptionally active DNA region that rearranges frequently in murine lymphoid tumors. Proc Natl Acad Sci U S A (1982) 2.16
Phosphorylation of ADF/cofilin abolishes EGF-induced actin nucleation at the leading edge and subsequent lamellipod extension. J Cell Biol (2000) 2.10
Nucleotide sequence of immunoglobulin heavy chain joining segments between translocated VH and mu constant regions genes. Proc Natl Acad Sci U S A (1980) 2.06
Mutations in JAGGED1 gene are predominantly sporadic in Alagille syndrome. Gastroenterology (1999) 2.06
The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology (2001) 1.99
Cytoskeletal changes regulated by the PAK4 serine/threonine kinase are mediated by LIM kinase 1 and cofilin. J Biol Chem (2001) 1.93
bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene (1996) 1.87
Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology (1988) 1.79
Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood (1993) 1.74
Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice. Science (1985) 1.70
Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome. J Virol (1988) 1.68
Autoimmune hepatitis with initial presentation as acute hepatic failure in young children. J Pediatr (1990) 1.61
A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein. EMBO J (1997) 1.60
Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children. Transplantation (2001) 1.59
Spontaneous perforation of the biliary tract in infancy: a series of 11 cases. Eur J Pediatr Surg (1996) 1.58
Jagged1 mutations in alagille syndrome. Hum Mutat (2001) 1.53
Transient neonatal cholestasis: origin and outcome. J Pediatr (1998) 1.53
Anti-liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum. J Exp Med (1985) 1.52
Current lifestyle of young adults after liver transplantation during childhood. Am J Transplant (2010) 1.51
NTBC treatment in tyrosinaemia type I: long-term outcome in French patients. J Inherit Metab Dis (2008) 1.48
Seroimmunologic classification of chronic hepatitis in 57 children. Hepatology (1983) 1.48
Estrogen and Bcl-2: gene induction and effect of transgene in experimental stroke. J Neurosci (2001) 1.46
Fatal acute fulminant liver failure due to clozapine: a case report and review of clozapine-induced hepatotoxicity. Gastroenterology (1997) 1.44
Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr (1985) 1.43
Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology (1996) 1.41
Incidence of cirrhosis in children with chronic hepatitis. J Pediatr (1990) 1.41
Organization of genes and spacers within the mouse immunoglobulin VH locus. J Mol Appl Genet (1981) 1.41
Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet (1999) 1.41
False-positive result of hepatitis C enzyme-linked immunosorbent assay in children with autoimmune hepatitis. J Pediatr (1991) 1.40
Portal obstruction in children. I. Clinical investigation and hemorrhage risk. J Pediatr (1983) 1.40
TEL is a sequence-specific transcriptional repressor. J Biol Chem (1999) 1.39
[Alagille syndrome in 1995. Clinical and genetic data]. Gastroenterol Clin Biol (1995) 1.38
Unusual early presentation of Gilbert syndrome in pediatric recipients of liver transplantation. J Pediatr Gastroenterol Nutr (2000) 1.37
JAGGED1 gene expression during human embryogenesis elucidates the wide phenotypic spectrum of Alagille syndrome. Hepatology (2000) 1.34
Cholelithiasis in infancy: a study of 40 cases. J Pediatr (1993) 1.31
Outcome of liver disease in children with Alagille syndrome: a study of 163 patients. Gut (2001) 1.29
Social stress exacerbates stroke outcome by suppressing Bcl-2 expression. Proc Natl Acad Sci U S A (2001) 1.29
The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers. Clin Pharmacol Ther (2007) 1.28
mRNA for surface immunoglobulin gamma chains encodes a highly conserved transmembrane sequence and a 28-residue intracellular domain. Proc Natl Acad Sci U S A (1982) 1.28
Long-term follow-up of growth in height after successful liver transplantation. J Pediatr (1994) 1.28
Alpha1-antitrypsin deficiency and liver disease in children: phenotypes, manifestations, and prognosis. Pediatrics (1976) 1.27
TEL-JAK2 transgenic mice develop T-cell leukemia. Blood (2000) 1.26
Portal obstruction in children. II. Results of surgical portosystemic shunts. J Pediatr (1983) 1.26
Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology (1997) 1.25
Neonatal cholestasis and hypoglycemia: possible role of cortisol deficiency. J Pediatr (1981) 1.24
Congenital hepatic fibrosis in children. J Pediatr (1981) 1.24
Plasmacytomas with more than one immunoglobulin kappa mRNA: implications for allelic exclusion. Proc Natl Acad Sci U S A (1981) 1.24
A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies. Oncogene (1995) 1.23
The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene. Blood (1995) 1.22
Pulmonary arteriovenous shunting in children with liver disease. J Pediatr (1995) 1.22
Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency. J Pediatr (1981) 1.20
Early assessment of evolution of liver disease associated with alpha 1-antitrypsin deficiency in childhood. J Pediatr (1983) 1.20
Liver disease associated with anti-liver-kidney microsome antibody in children. J Pediatr (1986) 1.19
bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc Natl Acad Sci U S A (1995) 1.18
Organization and expression of murine immunoglobulin genes. Immunol Rev (1981) 1.17
Transport of nucleosides. Ann N Y Acad Sci (1975) 1.17
Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily. J Exp Med (1988) 1.16
Immortalization of mouse neural precursor cells by the c-myc oncogene. Proc Natl Acad Sci U S A (1988) 1.15
Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice. Proc Natl Acad Sci U S A (1987) 1.15
Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents. J Pediatr Gastroenterol Nutr (1993) 1.15
DNA replication in isolated HeLa cell nuclei. Biochem Biophys Res Commun (1973) 1.14
Congenital portosystemic shunts in children: recognition, evaluation, and management. Semin Liver Dis (2013) 1.14
Mapping of microsatellite markers in the Alagille region and screening of microdeletions by genotyping 23 patients. Eur J Hum Genet (1994) 1.12
Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway. Oncogene (2001) 1.11
DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc Natl Acad Sci U S A (1996) 1.11
Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity. Proc Natl Acad Sci U S A (1998) 1.11
Bacterial cholangitis after surgery for biliary atresia. J Pediatr (1987) 1.10
Implication of Bcl-2 and Caspase-3 in age-related Purkinje cell death in murine organotypic culture: an in vitro model to study apoptosis. Eur J Neurosci (2000) 1.10
Presence of HBV DNA in spermatozoa: a possible vertical transmission of HBV via the germ line. J Med Virol (1985) 1.09